
...
By Jackson Roberts
Contributing Sports Writer
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
Every team loads up on arms during the offseason, but the San Francisco Giants' stockade reportedly includes a pitcher who hasn't seen Major League Baseball action since 2021.
Nick Margevicius, who threw 32 games for the San Diego Padres and Seattle Mariners from 2019 to 2021, has had a windy path through professional baseball over the last few years. His recent stops include Chinese Professional Baseball and the Detroit Tigers' Triple-A team, the Toledo Mud Hens.
According to a Friday report from Alex Pavlovic of NBC Sports Bay Area, the Giants and Margevicius agreed upon a minor-league contract for the upcoming season. Steve Adams of MLB Trade Rumors also reported Friday that Margevicius will receive a salary of $825,000 if he makes the major league roster.
Read More on MLB

...
The 29-year-old Margevicius will be out to prove that he not only has what it takes to make it back to the majors, but that he can succeed this time around. He posted a 6.12 ERA in 110 1/3 career innings before hitting the injured list with thoracic outlet syndrome in 2021.
After that setback, Margevicius posted a 7.53 ERA in Triple-A for the Mariners in 2022, causing his release the following March. He struggled mightily with the Atlanta Braves' Triple-A team in 2023 as well, but his return to the U.S. this season produced a solid 3.89 ERA in 74 innings for Toledo.
Margevicius is stretched out as a starter, but one figures he would be able to handle middle or long-relief duties in San Francisco if he pitched well enough in spring training to crack the 26-man roster.
If Margevicius has a midseason opt-out in his contract, he may be able to hit free agency after a month or two of the regular season, but as of Sunday, that information was not yet known.
More MLB: Blue Jays Veteran Named Free-Agent Fit For AL Rival Astros
View 0 Comments
Submit Correction
View Editorial & AI Guidelines